
Loading, please wait...

Loading, please wait...

Physicians recently identified a rare case of neonatal mesenchymal hamartoma in the right ventricle of a newborn infant. This condition is particularly unusual because most documented cases typically occur in the left ventricle. Consequently, the mass led to significant clinical complications, including pericardial effusion and cardiac tamponade shortly after birth. Because early diagnosis is vital, this case highlights the critical role of advanced imaging in neonatal cardiology.
Clinicians initially suspected the cardiac mass during prenatal screenings. However, the definitive diagnosis required comprehensive postnatal investigation using advanced diagnostic tools. Specifically, cardiac MRI provided detailed visualization of the right ventricular mass and its relationship with surrounding cardiac structures. Furthermore, histopathological analysis confirmed the tumor as a mesenchymal hamartoma. Because these tumors can cause life-threatening hemodynamic instability, prompt recognition and characterization are essential for improving neonatal survival rates.
While many cardiac tumors in neonates are histologically benign, their location often dictates the severity of clinical symptoms. Specifically, a right ventricular mass can obstruct blood flow or lead to rapid fluid accumulation in the pericardial sac. Therefore, a multidisciplinary team including neonatologists and cardiothoracic surgeons must manage such cases with urgency. Treatment strategies typically focus on relieving intrapericardial pressure and preventing further cardiac compromise. Additionally, long-term monitoring ensures that the patient remains stable following initial stabilization or surgical intervention.
Symptoms often include respiratory distress, cyanosis, and poor feeding. In severe cases, signs of cardiac tamponade such as hypotension and muffled heart sounds may appear.
Physicians primarily use echocardiography and cardiac MRI to assess tumor morphology and location. However, histopathology remains the gold standard for distinguishing mesenchymal hamartomas from rhabdomyomas or fibromas.
Surgery is usually necessary if the mass causes hemodynamic obstruction, life-threatening arrhythmias, or persistent pericardial effusion. Asymptomatic cases may occasionally be managed with close observation.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Explore a rare case of neonatal right ventricular mesenchymal hamartoma causing cardiac tamponade, highlighting the roles of MRI and histopathology in diagn...
5 months ago

A study evaluates the diagnostic performance of repeat transthoracic echocardiography in suspected infective endocarditis, showing modest improvements in lesion detection but limited incremental value within a multimodality imaging approach.
Today

A multicenter study identifies a three-metabolite gut microbiota panel (3-hydroxydecanoic acid, γ-Glu-Leu, and propionic acid) for early risk stratification of gestational diabetes mellitus in the first trimester, offering superior predictive accuracy over standard clinical risk factors before 24 weeks.
Today

A breakthrough study reveals how METTL14-mediated m6A methylation of KRT17 drives pulmonary arterial smooth muscle cell proliferation via LCN2, offering new therapeutic targets for pulmonary vascular remodeling.
Today

A novel multi-strategy C2 screw placement protocol integrating fusion cage support and vertebral artery mobilization achieves superior fusion rates and zero vascular complications in complex upper cervical spine surgery, offering a reliable solution for high-riding vertebral artery cases.
Today

Discover clinical pitfalls in diagnosing SGLT2 inhibitor ketoacidosis in the ICU. Learn how cardiac surgery and GLP-1 agonist interactions trigger euglycemic DKA and explore management strategies.
Today